Nexalin Technology (NXL) Amortizatization of Intangibles (2023 - 2026)
Nexalin Technology (NXL) posted Amortizatization of Intangibles of $20325.0 for Q2 2026, up 201.74% on a QoQ basis from $6736.0 in Q1 2026, and up 296.51% year-over-year from $5126.0 in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Nexalin Technology has reported Amortizatization of Intangibles for 4 years, with the latest figure at $20325.0 in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 296.51% year-over-year to $20325.0 in Q2 2026; TTM through Jun 2026 was $38686.0, a 108.39% increase from a year earlier, with the FY2025 full-year figure at $21537.0, up 42.56% from the prior year.
- Amortizatization of Intangibles was $20325.0 for Q2 2026 at Nexalin Technology, up from $6736.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $20325.0 in Q2 2026, with the low at $660.0 in Q1 2023.
- Average Amortizatization of Intangibles over 4 years is $4818.3, with a median of $4326.0 recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles jumped 459.23% in 2024, then gained 29.97% in 2025.
- Over 4 years, Amortizatization of Intangibles stood at $1646.0 in 2023, then surged by 169.81% to $4441.0 in 2024, then surged by 38.53% to $6152.0 in 2025, then soared by 230.38% to $20325.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $20325.0 (Q2 2026), $6736.0 (Q1 2026), and $6152.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | 20,325.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,325.00 |
| Mar 31, 2026 | 6,736.00 |
| Dec 31, 2025 | 6,152.00 |
| Sep 30, 2025 | 5,473.00 |
| Jun 30, 2025 | 5,126.00 |
| Mar 31, 2025 | 4,786.00 |
| Dec 31, 2024 | 4,441.00 |
| Sep 30, 2024 | 4,211.00 |
| Jun 30, 2024 | 3,793.00 |
| Mar 31, 2024 | 2,662.00 |
| Dec 31, 2023 | 1,646.00 |
| Sep 30, 2023 | 753.00 |
| Jun 30, 2023 | 692.00 |
| Mar 31, 2023 | 660.00 |